New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 29, 2012
10:00 EDTARUN, ULTI, WDC, OAS, WX, TXN, MXIM, EMC, VAL, NTAP, LNCO, CHTR, VMW, RPM, JAZZOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Charter (CHTR) initiated with a Buy at UBS... EMC (EMC) initiated with a Buy at Buckingham... EMC (EMC) initiated with a Buy at CLSA... Jazz Pharmaceuticals (JAZZ) initiated with a Buy at UBS... LinnCo (LNCO) initiated with a Buy at Citigroup... Maxim Integrated (MXIM) initiated with a Buy at SunTrust... NXP Semiconductors (NXPI) initiated with a Buy at SunTrust... NetApp (NTAP) initiated with an Underperform at CLSA... RPM (RPM) initiated with an Overweight at Morgan Stanley... Texas Instruments (TXN) initiated with a Reduce at SunTrust... VMware (VMW) initiated with a Buy at CLSA... Valspar (VAL) initiated with an Underweight at Morgan Stanley... WuXi PharmaTech (WX) initiated with an Overweight at Barclays... Oasis Petroleum (OAS) initiated with a Buy at Ladenburg... Ultimate Software (ULTI) initiated with an Outperform at Northland Securities... Aruba Networks (ARUN) initiated with a Hold at Craig-Hallum... Western Digital (WDC) initiated with a Market Perform at Wells Fargo.
News For CHTR;EMC;JAZZ;LNCO;MXIM;RPM;NTAP;TXN;VMW;VAL;WX;OAS;ULTI;ARUN;WDC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 21, 2015
15:02 EDTEMCNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Coca-Cola (KO), consensus 60c... Boeing (BA), consensus $1.42... Abbott Laboratories (ABT), consensus 50c... Thermo Fisher Scientific (TMO), consensus $1.78... EMC (EMC), consensus 41c... Illinois Tool Works (ITW), consensus $1.28... St. Jude Medical (STJ), consensus $1.00... Northern Trust (NTRS), consensus 96c... Check Point Software (CHKP), consensus 95c... Polaris Industries (PII), consensus $1.58... Interpublic Group (IPG), consensus 27c... New York Community Bancorp (NYCB), consensus 26c... B/E Aerospace (BEAV), consensus 76c... Owens Corning (OC), consensus 54c... Knight Transportation (KNX), consensus 37c.
15:02 EDTVMWNotable companies reporting after market close
Subscribe for More Information
14:24 EDTVMW, NTAP, EMCEarnings Watch: EMC reports amid M&A speculation in sector
Subscribe for More Information
13:59 EDTEMCEMC technical notes ahead of earnings
The key feature on a long-term chart is a potential compound bearish head and shoulders pattern. Shares are directly on the neckline of that pattern ahead of earnings. A move below $24 would confirm that the pattern is active. Downside potential would be to the $16 area over time, presuming the pattern was not interrupted. If the news is a bullish surprise, resistance levels to watch as potential upside objectives are at $26.17, $27.73, and $29.04. A move above $27.50 that sustained for several months would void the head and shoulders pattern.
13:28 EDTTXNTexas Instruments July weekly volatility elevated into Q2 and outlook
Subscribe for More Information
10:50 EDTVMWVMware technical notes ahead of earnings news
Subscribe for More Information
10:01 EDTLNCOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:00 EDTEMCEMC July weekly volatility elevated into Q2 and outlook
Subscribe for More Information
08:05 EDTVMWVMware July weekly volatility elevated into Q4 and outlook
Subscribe for More Information
07:23 EDTLNCOLinnCo downgraded to Outperform at Raymond James
Subscribe for More Information
07:17 EDTLNCOLinnCo downgraded to Outperform from Strong Buy at Raymond James
July 20, 2015
10:26 EDTJAZZLeerink's specialty pharma/generics analyst has analyst/industry conference call
Specialty Pharmaceuticals / Generics Analyst Gerberry, along with MEDACorp Specialists Michael Belliveau, PhD and Shashank Upadhye, JD, discuss the strengths and weaknesses of TEVA's preliminary responses to the IPR challenge on Copaxone 40mg, the likely outcomes for the Copaxone 40mg patent challenge and perspectives on recent updates in the JAZZ Xyrem patent case on an Analyst/Industry conference call to be held on July 22 at 2 pm.
10:17 EDTLNCOHigh option volume stocks
Subscribe for More Information
10:00 EDTTXNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:48 EDTTXNTexas Instruments upgraded to Buy at UBS
As reported previously, UBS upgraded Texas Instruments to Buy from Neutral as their proprietary model suggests Q2 revenues should beat consensus by 2%. The firm said with the recent pullback, expectations for bad news and evidence of stable demand its Q2 revenue beat should surprise the Street view. UBS maintained its $55 price target on Texas Instruments shares.
08:19 EDTVMWSentiment towards VMware overly negative, says RBC Capital
Subscribe for More Information
07:59 EDTTXNTexas Instruments upgraded to Buy from Neutral at UBS
Subscribe for More Information
July 17, 2015
08:38 EDTJAZZLeerink puts 25% odds on Teva, Mylan deal within 12 months
Subscribe for More Information
07:41 EDTCHTRRovi ruling in Netflix suit may 'embolden' pay TV providers, says Stephens
Subscribe for More Information
07:30 EDTCHTRCablevision downgraded to Hold from Buy at Jefferies
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use